Proactiveinvestors USA & Canada Orgenesis https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Orgenesis RSS feed en Thu, 22 Aug 2019 21:47:11 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - NA Proactive news snapshot: Duos Technologies, Lydian International, CytoDyn, BevCanna Enterprises ... ]]> https://www.proactiveinvestors.com/companies/news/900766/na-proactive-news-snapshot-duos-technologies-lydian-international-cytodyn-bevcanna-enterprises--900766.html Wed, 14 Aug 2019 10:00:00 -0400 https://www.proactiveinvestors.com/companies/news/900766/na-proactive-news-snapshot-duos-technologies-lydian-international-cytodyn-bevcanna-enterprises--900766.html <![CDATA[News - Orgenesis realigns resources with internal business transfers to support continued growth ]]> https://www.proactiveinvestors.com/companies/news/900763/orgenesis-realigns-resources-with-internal-business-transfers-to-support-continued-growth-900763.html Wed, 14 Aug 2019 09:45:00 -0400 https://www.proactiveinvestors.com/companies/news/900763/orgenesis-realigns-resources-with-internal-business-transfers-to-support-continued-growth-900763.html <![CDATA[News - Orgenesis Inc sees record fiscal 2Q revenue beat estimates ]]> https://www.proactiveinvestors.com/companies/news/900553/orgenesis-inc-sees-record-fiscal-2q-revenue-beat-estimates-900553.html Mon, 12 Aug 2019 10:45:00 -0400 https://www.proactiveinvestors.com/companies/news/900553/orgenesis-inc-sees-record-fiscal-2q-revenue-beat-estimates-900553.html <![CDATA[News - Orgenesis gets Orphan Drug designation to treat severe diabetes ]]> https://www.proactiveinvestors.com/companies/news/313923/orgenesis-gets-orphan-drug-designation-to-treat-severe-diabetes-13923.html Fri, 28 Jun 2019 12:40:00 -0400 https://www.proactiveinvestors.com/companies/news/313923/orgenesis-gets-orphan-drug-designation-to-treat-severe-diabetes-13923.html <![CDATA[News - Orgenesis wins Orphan Drug designation for AIP cells for treating severe diabetes ]]> https://www.proactiveinvestors.com/companies/news/222236/orgenesis-wins-orphan-drug-designation-for-aip-cells-for-treating-severe-diabetes-222236.html Mon, 17 Jun 2019 08:04:00 -0400 https://www.proactiveinvestors.com/companies/news/222236/orgenesis-wins-orphan-drug-designation-for-aip-cells-for-treating-severe-diabetes-222236.html <![CDATA[News - Orgenesis explains the impacts of it's cell therapy development and manufacturing tech ]]> https://www.proactiveinvestors.com/companies/news/313628/orgenesis-explains-the-impacts-of-it-s-cell-therapy-development-and-manufacturing-tech-13628.html Wed, 05 Jun 2019 16:26:00 -0400 https://www.proactiveinvestors.com/companies/news/313628/orgenesis-explains-the-impacts-of-it-s-cell-therapy-development-and-manufacturing-tech-13628.html <![CDATA[News - Orgenesis posts record fiscal 1Q profit, $7.3M in revenue as its contact manufacturing business booms ]]> https://www.proactiveinvestors.com/companies/news/219993/orgenesis-posts-record-fiscal-1q-profit-73m-in-revenue-as-its-contact-manufacturing-business-booms-219993.html Thu, 09 May 2019 10:23:00 -0400 https://www.proactiveinvestors.com/companies/news/219993/orgenesis-posts-record-fiscal-1q-profit-73m-in-revenue-as-its-contact-manufacturing-business-booms-219993.html <![CDATA[News - Orgenesis CEO talks through most recent collaborations: 3D cell printing and exosome technologies ]]> https://www.proactiveinvestors.com/companies/news/313173/orgenesis-ceo-talks-through-most-recent-collaborations-3d-cell-printing-and-exosome-technologies-13173.html Wed, 01 May 2019 09:41:00 -0400 https://www.proactiveinvestors.com/companies/news/313173/orgenesis-ceo-talks-through-most-recent-collaborations-3d-cell-printing-and-exosome-technologies-13173.html <![CDATA[News - Orgenesis to study liver cells as a suitable source for cell replacement therapy for insulin-dependent diabetics ]]> https://www.proactiveinvestors.com/companies/news/219401/orgenesis-to-study-liver-cells-as-a-suitable-source-for-cell-replacement-therapy-for-insulin-dependent-diabetics-219401.html Tue, 30 Apr 2019 12:17:00 -0400 https://www.proactiveinvestors.com/companies/news/219401/orgenesis-to-study-liver-cells-as-a-suitable-source-for-cell-replacement-therapy-for-insulin-dependent-diabetics-219401.html <![CDATA[News - Orgenesis strikes deal with Columbia University to develop Cellular Vaccination product platform ]]> https://www.proactiveinvestors.com/companies/news/218894/orgenesis-strikes-deal-with-columbia-university-to-develop-cellular-vaccination-product-platform-218894.html Mon, 22 Apr 2019 10:39:00 -0400 https://www.proactiveinvestors.com/companies/news/218894/orgenesis-strikes-deal-with-columbia-university-to-develop-cellular-vaccination-product-platform-218894.html <![CDATA[News - Orgenesis strikes collaboration, license deal for exosome technologies with ExcellaBio ]]> https://www.proactiveinvestors.com/companies/news/218434/orgenesis-strikes-collaboration-license-deal-for-exosome-technologies-with-excellabio-218434.html Thu, 11 Apr 2019 10:04:00 -0400 https://www.proactiveinvestors.com/companies/news/218434/orgenesis-strikes-collaboration-license-deal-for-exosome-technologies-with-excellabio-218434.html <![CDATA[News - Orgenesis strikes deal to develop 3D printing for cellular structures and tissues ]]> https://www.proactiveinvestors.com/companies/news/217991/orgenesis-strikes-deal-to-develop-3d-printing-for-cellular-structures-and-tissues-217991.html Thu, 04 Apr 2019 11:48:00 -0400 https://www.proactiveinvestors.com/companies/news/217991/orgenesis-strikes-deal-to-develop-3d-printing-for-cellular-structures-and-tissues-217991.html <![CDATA[News - Orgenesis showcases publication of diabetes study in Stem Cell Research and Therapy Journal ]]> https://www.proactiveinvestors.com/companies/news/217889/orgenesis-showcases-publication-of-diabetes-study-in-stem-cell-research-and-therapy-journal-217889.html Wed, 03 Apr 2019 10:38:00 -0400 https://www.proactiveinvestors.com/companies/news/217889/orgenesis-showcases-publication-of-diabetes-study-in-stem-cell-research-and-therapy-journal-217889.html <![CDATA[News - Orgenesis gains after announcing venture with TheraCell for cell and gene therapy development ]]> https://www.proactiveinvestors.com/companies/news/217442/orgenesis-gains-after-announcing-venture-with-theracell-for-cell-and-gene-therapy-development-217442.html Thu, 28 Mar 2019 09:52:00 -0400 https://www.proactiveinvestors.com/companies/news/217442/orgenesis-gains-after-announcing-venture-with-theracell-for-cell-and-gene-therapy-development-217442.html <![CDATA[News - Orgenesis subsidiary MaSTherCell Global to build new facility in Belgium for cell and gene therapy manufacturing ]]> https://www.proactiveinvestors.com/companies/news/217146/orgenesis-subsidiary-masthercell-global-to-build-new-facility-in-belgium-for-cell-and-gene-therapy-manufacturing-217146.html Mon, 25 Mar 2019 10:35:00 -0400 https://www.proactiveinvestors.com/companies/news/217146/orgenesis-subsidiary-masthercell-global-to-build-new-facility-in-belgium-for-cell-and-gene-therapy-manufacturing-217146.html <![CDATA[News - Orgenesis leads the charge at an exciting time for cell therapy ]]> https://www.proactiveinvestors.com/companies/news/216323/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-therapy-216323.html Tue, 12 Mar 2019 15:30:00 -0400 https://www.proactiveinvestors.com/companies/news/216323/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-therapy-216323.html <![CDATA[News - Orgenesis stock climbs after it posts 139% expansion in gross profit for fiscal 2018 on revenue surge ]]> https://www.proactiveinvestors.com/companies/news/214660/orgenesis-stock-climbs-after-it-posts-139-expansion-in-gross-profit-for-fiscal-2018-on-revenue-surge-214660.html Thu, 14 Feb 2019 10:14:00 -0500 https://www.proactiveinvestors.com/companies/news/214660/orgenesis-stock-climbs-after-it-posts-139-expansion-in-gross-profit-for-fiscal-2018-on-revenue-surge-214660.html <![CDATA[News - Orgenesis unveils new offices, labs at Accessia Pharma in Belgium to boost its point-of-care cellular therapy platform ]]> https://www.proactiveinvestors.com/companies/news/214020/orgenesis-unveils-new-offices-labs-at-accessia-pharma-in-belgium-to-boost-its-point-of-care-cellular-therapy-platform-214020.html Tue, 05 Feb 2019 10:24:00 -0500 https://www.proactiveinvestors.com/companies/news/214020/orgenesis-unveils-new-offices-labs-at-accessia-pharma-in-belgium-to-boost-its-point-of-care-cellular-therapy-platform-214020.html <![CDATA[News - Orgenesis subsidiary MaSTherCell Global expanding into the US ]]> https://www.proactiveinvestors.com/companies/news/312058/orgenesis-subsidiary-masthercell-global-expanding-into-the-us-12058.html Thu, 31 Jan 2019 15:15:00 -0500 https://www.proactiveinvestors.com/companies/news/312058/orgenesis-subsidiary-masthercell-global-expanding-into-the-us-12058.html <![CDATA[News - Orgenesis kicks off US expansion of MaSTherCell Global subsidiary with Houston facility ]]> https://www.proactiveinvestors.com/companies/news/213368/orgenesis-kicks-off-us-expansion-of-masthercell-global-subsidiary-with-houston-facility-213368.html Fri, 25 Jan 2019 10:20:00 -0500 https://www.proactiveinvestors.com/companies/news/213368/orgenesis-kicks-off-us-expansion-of-masthercell-global-subsidiary-with-houston-facility-213368.html <![CDATA[News - HekaBio CEO says Orgenesis taken 'great steps' to solve biotech manufacturing cost problem ]]> https://www.proactiveinvestors.com/companies/news/311814/hekabio-ceo-says-orgenesis-taken--great-steps--to-solve-biotech-manufacturing-cost-problem-11814.html Fri, 11 Jan 2019 13:51:00 -0500 https://www.proactiveinvestors.com/companies/news/311814/hekabio-ceo-says-orgenesis-taken--great-steps--to-solve-biotech-manufacturing-cost-problem-11814.html <![CDATA[News - Orgenesis CEO says investors realizing building out infrastructure in biotechs is important ]]> https://www.proactiveinvestors.com/companies/news/311789/orgenesis-ceo-says-investors-realizing-building-out-infrastructure-in-biotechs-is-important-11789.html Thu, 10 Jan 2019 15:48:00 -0500 https://www.proactiveinvestors.com/companies/news/311789/orgenesis-ceo-says-investors-realizing-building-out-infrastructure-in-biotechs-is-important-11789.html <![CDATA[News - Biotech CEOs gather in San Francisco to mull 2019 outlook ]]> https://www.proactiveinvestors.com/companies/news/211991/biotech-ceos-gather-in-san-francisco-to-mull-2019-outlook-211991.html Fri, 04 Jan 2019 13:05:00 -0500 https://www.proactiveinvestors.com/companies/news/211991/biotech-ceos-gather-in-san-francisco-to-mull-2019-outlook-211991.html <![CDATA[News - Orgenesis to present at Biotech Showcase in San Francisco next week ]]> https://www.proactiveinvestors.com/companies/news/311698/orgenesis-to-present-at-biotech-showcase-in-san-francisco-next-week-11698.html Thu, 03 Jan 2019 12:02:00 -0500 https://www.proactiveinvestors.com/companies/news/311698/orgenesis-to-present-at-biotech-showcase-in-san-francisco-next-week-11698.html <![CDATA[News - Orgenesis among small-caps presenting at Diamond Equity Research's 'Emerging Growth Invitational' in New York ]]> https://www.proactiveinvestors.com/companies/news/311688/orgenesis-among-small-caps-presenting-at-diamond-equity-research-s--emerging-growth-invitational--in-new-york-11688.html Fri, 21 Dec 2018 12:33:00 -0500 https://www.proactiveinvestors.com/companies/news/311688/orgenesis-among-small-caps-presenting-at-diamond-equity-research-s--emerging-growth-invitational--in-new-york-11688.html <![CDATA[News - Orgenesis collaborates with MangoGen Pharma for advanced gene delivery platform ]]> https://www.proactiveinvestors.com/companies/news/211435/orgenesis-collaborates-with-mangogen-pharma-for-advanced-gene-delivery-platform-211435.html Tue, 18 Dec 2018 14:57:00 -0500 https://www.proactiveinvestors.com/companies/news/211435/orgenesis-collaborates-with-mangogen-pharma-for-advanced-gene-delivery-platform-211435.html <![CDATA[News - Orgenesis CEO Vered Caplan says it's a 'very exciting time' for cell therapy in Fox interview ]]> https://www.proactiveinvestors.com/companies/news/211174/orgenesis-ceo-vered-caplan-says-it-s-a--very-exciting-time--for-cell-therapy-in-fox-interview-211174.html Thu, 13 Dec 2018 10:45:00 -0500 https://www.proactiveinvestors.com/companies/news/211174/orgenesis-ceo-vered-caplan-says-it-s-a--very-exciting-time--for-cell-therapy-in-fox-interview-211174.html <![CDATA[News - Orgenesis seals pact with Ben-Gurion University to develop dissolvable carriers for cell culturing ]]> https://www.proactiveinvestors.com/companies/news/211072/orgenesis-seals-pact-with-ben-gurion-university-to-develop-dissolvable-carriers-for-cell-culturing-211072.html Wed, 12 Dec 2018 09:36:00 -0500 https://www.proactiveinvestors.com/companies/news/211072/orgenesis-seals-pact-with-ben-gurion-university-to-develop-dissolvable-carriers-for-cell-culturing-211072.html <![CDATA[News - Orgenesis subsidiary Masthercell Global unveils new production wing at Belgian plant ]]> https://www.proactiveinvestors.com/companies/news/210320/orgenesis-subsidiary-masthercell-global-unveils-new-production-wing-at-belgian-plant-210320.html Fri, 30 Nov 2018 09:22:00 -0500 https://www.proactiveinvestors.com/companies/news/210320/orgenesis-subsidiary-masthercell-global-unveils-new-production-wing-at-belgian-plant-210320.html <![CDATA[News - Orgenesis teams up with New York Blood Center for tissue collection, biobanking US cell therapy development program ]]> https://www.proactiveinvestors.com/companies/news/209693/orgenesis-teams-up-with-new-york-blood-center-for-tissue-collection-biobanking-us-cell-therapy-development-program-209693.html Wed, 21 Nov 2018 10:11:00 -0500 https://www.proactiveinvestors.com/companies/news/209693/orgenesis-teams-up-with-new-york-blood-center-for-tissue-collection-biobanking-us-cell-therapy-development-program-209693.html <![CDATA[News - Orgenesis teams up with HemoGenyx in second collaboration to push cancer cell replacement product to clinical trials ]]> https://www.proactiveinvestors.com/companies/news/311105/orgenesis-teams-up-with-hemogenyx-in-second-collaboration-to-push-cancer-cell-replacement-product-to-clinical-trials-11105.html Mon, 05 Nov 2018 11:09:00 -0500 https://www.proactiveinvestors.com/companies/news/311105/orgenesis-teams-up-with-hemogenyx-in-second-collaboration-to-push-cancer-cell-replacement-product-to-clinical-trials-11105.html <![CDATA[News - Orgenesis teams up with HemoGenyx to develop its AHC platform in ‘exciting’ deal ]]> https://www.proactiveinvestors.com/companies/news/311104/orgenesis-teams-up-with-hemogenyx-to-develop-its-ahc-platform-in-exciting-deal-11104.html Mon, 05 Nov 2018 11:02:00 -0500 https://www.proactiveinvestors.com/companies/news/311104/orgenesis-teams-up-with-hemogenyx-to-develop-its-ahc-platform-in-exciting-deal-11104.html <![CDATA[News - Orgenesis CEO says companies looking for ways to get costs of medicine down ]]> https://www.proactiveinvestors.com/companies/news/208450/orgenesis-ceo-says-companies-looking-for-ways-to-get-costs-of-medicine-down-208450.html Fri, 02 Nov 2018 16:17:00 -0400 https://www.proactiveinvestors.com/companies/news/208450/orgenesis-ceo-says-companies-looking-for-ways-to-get-costs-of-medicine-down-208450.html <![CDATA[News - Orgenesis' cell therapy development business pushes into the US ]]> https://www.proactiveinvestors.com/companies/news/311058/orgenesis-cell-therapy-development-business-pushes-into-the-us-11058.html Wed, 31 Oct 2018 08:51:00 -0400 https://www.proactiveinvestors.com/companies/news/311058/orgenesis-cell-therapy-development-business-pushes-into-the-us-11058.html <![CDATA[News - Orgenesis, Geneius to present at 'The Cellular Living Drug Revolution Summit' in New York ]]> https://www.proactiveinvestors.com/companies/news/310974/orgenesis-geneius-to-present-at-the-cellular-living-drug-revolution-summit-in-new-york-10974.html Wed, 24 Oct 2018 16:42:00 -0400 https://www.proactiveinvestors.com/companies/news/310974/orgenesis-geneius-to-present-at-the-cellular-living-drug-revolution-summit-in-new-york-10974.html <![CDATA[News - Orgenesis revenue nearly doubled in fiscal second quarter on CAR T-cell therapies ]]> https://www.proactiveinvestors.com/companies/news/200984/orgenesis-revenue-nearly-doubled-in-fiscal-second-quarter-on-car-t-cell-therapies-200984.html Tue, 17 Jul 2018 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/200984/orgenesis-revenue-nearly-doubled-in-fiscal-second-quarter-on-car-t-cell-therapies-200984.html <![CDATA[News - Orgenesis to conduct clinical trials for Type 1 diabetes treatment in Russia ]]> https://www.proactiveinvestors.com/companies/news/119663/orgenesis-to-conduct-clinical-trials-for-type-1-diabetes-treatment-in-russia-119663.html Tue, 24 Nov 2015 11:41:00 -0500 https://www.proactiveinvestors.com/companies/news/119663/orgenesis-to-conduct-clinical-trials-for-type-1-diabetes-treatment-in-russia-119663.html <![CDATA[News - Orgenesis forms strategic collaboration with Lyfebulb ]]> https://www.proactiveinvestors.com/companies/news/119577/orgenesis-forms-strategic-collaboration-with-lyfebulb-119577.html Mon, 23 Nov 2015 08:16:00 -0500 https://www.proactiveinvestors.com/companies/news/119577/orgenesis-forms-strategic-collaboration-with-lyfebulb-119577.html